IFN-γ-induced IDO and WRS expression in microglia is differentially regulated by IL-4

GLIA

Volumn 55, Issue 13, 2007, Pages 1385-1396

  Yadav, Manisha C ^a,b   Burudi, E M E ^a,c   Alirezaei, Mehrdad ^a   Flynn, Claudia C ^a   Watry, Debbie D ^a   Lanigan, Caroline M ^a   Fox, Howard S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BURNHAM INSTITUTE   (United States)

^c INTERNATIONAL LIVESTOCK RESEARCH INSTITUTE   (Kenya)

Author keywords

Cytokine; Indoleamine 2,3 dioxygenase; Tryptophanyl tRNA synthetase

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 13; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PHOSPHOPROTEIN PHOSPHATASE 2A; STAT1 PROTEIN; STAT6 PROTEIN; TRYPTOPHAN TRANSFER RNA LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; IMMUNE RESPONSE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELLS, CULTURED; GENE EXPRESSION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-4; MICE; MICE, KNOCKOUT; MICROGLIA; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; TRYPTOPHAN-TRNA LIGASE;

EID: 34548211823     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20544     Document Type: Article

References (60)

1. Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN. 1997. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA 94:3627-3632.
2. Bach EA, Aguet M, Schreiber RD. 1997. The IFN γ receptor: A paradigm for cytokine receptor signaling. Annu Rev Immunol 15:563-591.
3. Bara H, Hainfellner JA, Kepplinger B, Mazal PR, Schmid H, Budka H. 2000. Kynurenic acid metabolism in the brain of HIV-1 infected patients. J Neural Transm 107:1127-1138.
4. Bialojan C, Takai A. 1988. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics Biochem J 256:283-290.
5. Boasso A, Herbeuval JP, Hardy AW, Winkler C, Shearer GM. 2005. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood 105-1574-1581.
6. Braun D, Longman RS, Albert ML. 2005. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 106:2375-2381.
7. Buch S, Sui Y, Potula R, Pinson D, Adany I, Li Z, Huang M, Li S, Dhillon N, Major E, Narayan O. 2004. Role of interleukin-4 and monocyte chemoattractant protein-1 in the neuropathogenesis of X4 simian human immunodeficiency virus infection in macaques. J Neurovirol 10(Suppl 1):118-124.
8. Burudi EM, Marcondes MC, Watry DD, Zandonatti M, Taffe MA, Fox HS. 2002. Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains. J Virol 76: 12233-12241.
9. Chaves AC, Ceravolo IP, Gomes JA, Zani CL, Romanha AJ, Gazzinelli RT. 2001. IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-γ. Eur J Immunol 31:333-344.
10. Darnell JE, Jr., Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
11. Dhillon NK, Sui Y, Potula R, Dhillon S, Adany I, Li Z, Villinger F, Pinson D, Narayan O, Buch S. 2005. Inhibition of pathogenic SHIV replication in macaques treated with antisense DNA of interleukin-4. Blood 105:3094-3099.
12. Doherty TM, Kastelein R, Menon S, Andrade S, Coffman RL. 1993. Modulation of murine macrophage function by IL-13. J Immunol 151:7151-7160.
13. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661-665.
14. Fleckner J, Martensen PM, Tolstrup AB, Kjeldgaard NO, Justesen J. 1995. Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine 7:70-77.
15. Friberg M, Jennings R, Alsarraj M, Dessureault S, Cantor A, Extermann M, Mellor AL, Munn DH, Antonia SJ. 2002. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int J Cancer 101:151-155.
16. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. 2002. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196:459-468.
17. Gomez TM, Spitzer NC. 1999. In vivo regulation of axon extension and pathfinding by growth-cone calcium transients. Nature 397: 350-355.
18. Grant RS, Naif H, Thuruthyil SJ, Nasr N, Littlejohn T, Takikawa O, Kapoor V. 2000. Induction of indolamine 2,3-dioxygenase in primary human macrophages by human immunodeficiency virus type 1 is strain dependent. J Virol 74:4110-4115.
19. Grohmann U, Fallarino F, Bianchi R, Orabona C, Vacca C, Fioretti MC, Puccetti P. 2003. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med 198:153-160.
20. Guillemin GJ, Brew BJ. 2002. Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease. Redox Rep 7:199-206.
21. Guillemin GJ, Smythe GA, Veas LA, Takikawa O, Brew BJ. 2003. A beta 1-42 induces production of quinolinic acid by human macrophages and microglia. Neuroreport 14:2311-2315.
22. Heyes MP, Rubinow D, Lane C, Markey SP. 1989. Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Ann Neurol 26:275-277.
23. Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A, Larson SA, Lee K, Leonard HL, Markey SP, Martin A, Milstein S, Mouradian MM, Pranzatelli MR, Quearry BJ, Salazar A, Smith M, Strauss SE, Sunde-land T, Swedo SW, Tourtellotte WW. 1992. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115(Part 5):1249-1273.
24. Hulshof S, Montagne L, De Groot CJ, Van Der Valk P. 2002. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. Glia 38:24-35.
25. Hwang SY, Jung JS, Lim SJ, Kim JY, Kim TH, Cho KH, Han IO. 2004. LY294002 inhibits interferon-gamma-stimulated inducible nitric oxide synthase expression in BV2 microglial cells. Biochem Biophys Res Commun 318:691-697.
26. Iribarren P, Chen K, Hu J, Zhang X, Gong W, Wang JM. 2005. IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-α-activated microglia. J Immunol 175: 6100-6016.
27. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. 2003. Interleukin-4 and interleukin-13 signaling connections maps. Science 300:1527-1528.
28. Kwidzinski E, Bunse J, Aktas O, Richter D, Mutlu L, Zipp F, Nitsch R, Bechmann I. 2005. Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J 19: 1347-1349.
29. Levings MK, Schrader JW. 1999. IL-4 inhibits the production of TNF-α and IL-12 by STAT6-dependent and -independent mechanisms. J Immunol 162:5224-5229.
30. Ludowyke RI, Holst J, Mudge LM, Sim AT. 2000. Transient translocation and activation of protein phosphatase 2A during mast cell secretion. J Biol Chem 275:6144-6152.
31. MacKenzie CR, Gonzalez RG, Kniep E, Roch S, Daubener W. 1999. Cytokine mediated regulation of interferon-gamma-induced IDO activation. Adv Exp Med Biol 467:533-539.
32. Maffei CM, Mirels LF, Sobel RA, Clemons KV, Stevens DA. 2004. Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis. Infect Immun 72:2338-2349.
33. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D. 2004. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103:4619-4621.
34. Mochizuki Y, Tsuda S, Kanetake H, Kanda S. 2002. Negative regulation of urokinase-type plasminogen activator production through FGF-2-mediated activation of phosphoinositide 3-kinase. Oncogene 21:7027-7033.
35. Mosmann TR, Sad S. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146.
36. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189:1363-1372.
37. Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ, Messina JL, Chandler P, Koni PA, Mellor AL. 2004. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114:280-290.
38. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-1193.
39. Murray MF. 2003. Tryptophan depletion and HIV infection: A metabolic link to pathogenesis. Lancet Infect Dis 3:644-652.
40. Musso T, Gusella GL, Brooks A, Longo DL, Varesio L. 1994. Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. Blood 83:1408-1411.
41. Nguyen MH, Ho JM, Beattie BK, Barber DL. 2001. TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3′-kinase/protein kinase B signaling pathway. J Biol Chem 276:32704-32713.
42. O'Keefe GM, Nguyen VT, Benveniste EN. 1999. Class II transactivator and class II MHC gene expression in microglia: Modulation by the cytokines TGF-β, IL-4, IL-13 and IL-10. Eur J Immunol 29:1275-1285.
43. Oswald IP, Gazzinelli RT, Sher A, James SL. 1992. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J Immunol 148:3578-3582.
44. Pahan K, Raymond JR, Singh I. 1999. Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells. J Biol Chem 274:7528-7536.
45. Popov A, Abdullah Z, Wickenhauser C, Saric T, Driesen J, Hanisch FG, Domann E, Raven EL, Dehus O, Hermann C, Eggle D, Debey S, Chakraborty T, Kronke M, Utermohler O, Schultze JL. 2006. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J Clin Invest 116:3160-3170.
46. Restrepo BI, Alvarez JI, Castano JA, Arias LF, Restrepo M, Trujillo J, Colegial CH, Teale JM. 2001. Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect Immun 69:4554-4560.
47. Robinson CM, Shirey KA, Carlin JM. 2003. Synergistic transcriptional activation of indoleamine dioxygenase by IFN-γ and tumor necrosis factor-alpha. J Interferon Cytokine Res 23:413-421.
48. Rubin BY, Anderson SL, Xing L, Powell RJ, Tate WP. 1991. Interferon induces tryptophanyl-tRNA synthetase expression in human fibroblasts. J Biol Chem 266:24245-24248.
49. Sakurai K, Zou JP, Tschetter JR, Ward JM, Shearer GM. 2002. Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 129:186-196.
50. Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen V. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci USA 88:7438-7442.
51. Shin WH, Lee DY, Park KW, Kim SU, Yang MS, Joe EH, Jin BK. 2004. Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo. Glia 46:142-152.
52. Stone TW. 2001. Kynurenines in the CNS: From endogenous obscurity to therapeutic importance. Prog Neurobiol 64:185-218.
53. Szczepanik AM, Funes S, Petko W, Ringheim GE. 2001. IL-4, IL-10 and IL-13 modulate A beta(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol 113:49-62.
54. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, Opelz G. 2002. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: Mediation of suppression by tryptophan metabolites. J Exp Med 196:447-457.
55. Vanhaesebroeck B, Waterneld MD. 1999. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253:239-254.
56. Wen Z, Zhong Z, Darnell JE Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250.
57. Widner B, Ledochowski M, Fuchs D. 2000. Interferon-gamma-induced tryptophan degradation: Neuropsychiatry; and immunological consequences. Curr Drug Metab 1:193-204.
58. Yoshida R, Imanishi J, Oku T, Kishida T, Hayaishi O. 1981. Induction of pulmonary indoleamine 2,3-dioxygenase by interferon. Proc Natl Acad Sci USA 78:129-132.
59. Yuan W, Collado-Hidalgo A, Yufit T, Taylor M, Varga J. 1998. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: Selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression. J Cell Physiol 177:174-186.
60. Zganiacz A, Santosuosso M, Wang J, Yang T, Chen L, Anzulovic M, Alexander S, Gicquel B, Wan Y, Bramson J, Inman M, Xing Z. 2004. TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest 113:401-413.